Evidence map›Paper›PMID 38562076›Full record

ArticleHaematologica2024

Srdan Verstovsek, Ruben Mesa, Moshe Talpaz, Jean-Jacques Kiladjian, Claire N Harrison, Stephen T Oh, Alessandro M Vannucchi, Raajit Rampal, Bart L Scott, Sarah A Buckley and 3 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 11 institutions in 4 countries.

Srdan VerstovsekMD Anderson Cancer Center, Houston, TX. srdanverstovsek@gmail.com.
Ruben MesaMayo Clinic, Scottsdale, AZ.
Moshe TalpazUniversity of Michigan, Comprehensive Cancer Center, Ann Arbor, MI.
Jean-Jacques KiladjianHôpital Saint Louis, Université Paris Diderot, Paris.
Claire N HarrisonGuy's and St Thomas' NHS Foundation Trust, London.
Stephen T OhWashington University School of Medicine, St. Louis, MO.
Alessandro M VannucchiUniversity of Florence, Azienda Ospedaliera-Universitaria Careggi, Florence.
Raajit RampalMemorial Sloan Kettering Cancer Center, New York, NY.
Bart L ScottFred Hutchinson Cancer Research Center, Seattle, WA.
Sarah A BuckleyCTI BioPharma Inc, Seattle, WA.
Adam R CraigCTI BioPharma Inc, Seattle, WA.
Karisse Roman-TorresCTI BioPharma Inc, Seattle, WA.
John O MascarenhasIcahn School of Medicine at Mount Sinai, New York, NY.
CTI BioPharma (United States) · USAzienda Ospedaliero-Universitaria Careggi · ITDélégation Paris 7 · FRFred Hutch Cancer Center · USGuy's and St Thomas' NHS Foundation Trust · GBIcahn School of Medicine at Mount Sinai · USMayo Clinic in Arizona · USMemorial Sloan Kettering Cancer Center · USMichigan Center for Translational Pathology · USThe University of Texas MD Anderson Cancer Center · USWashington University in St. Louis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38562076
PMCPMC10988197
OpenAlexW4393389942

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.